We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+47.61%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$664M
AUM Growth
+$53.7M
Cap. Flow
-$65.4M
Cap. Flow %
-9.85%
Top 10 Hldgs %
8.56%
Holding
488
New
196
Increased
26
Reduced
99
Closed
166

Top Sells

Rank Stock Value
1
APAM icon
Artisan Partners
APAM
+$7.7M
2
GNTX icon
Gentex
GNTX
+$7.08M
3
OCUL icon
Ocular Therapeutix
OCUL
+$6.06M
4
CELH icon
Celsius Holdings
CELH
+$5.29M
5
GRWG icon
GrowGeneration
GRWG
+$5.23M

Sector Composition

Rank Sector Weight
1 Technology 21.01%
2 Consumer Discretionary 19.32%
3 Industrials 18.98%
4 Healthcare 16.09%
5 Financials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDNA icon
351
CareDx
CDNA
$2.42B
-30,186
Closed -$2.19M
CELH icon
352
Celsius Holdings
CELH
$7.03B
-315,204
Closed -$5.29M
CHEF icon
353
Chefs' Warehouse
CHEF
$4.5B
-118,358
Closed -$3.04M
CLDX icon
354
Celldex Therapeutics
CLDX
$3.28B
-100,259
Closed -$1.76M
CLF icon
355
Cleveland-Cliffs
CLF
$6.99B
-142,647
Closed -$2.08M
CLPT icon
356
ClearPoint Neuro
CLPT
$433M
-105,928
Closed -$1.68M
CMT icon
357
Core Molding Technologies
CMT
$234M
-88,048
Closed -$1.24M
COHR icon
358
Coherent
COHR
$74.2B
-37,590
Closed -$2.85M
CRDF icon
359
Cardiff Oncology
CRDF
$77.2M
-45,517
Closed -$819K
CRMD icon
360
CorMedix
CRMD
$584M
-120,002
Closed -$892K
CRNC icon
361
Cerence
CRNC
$413M
-51,791
Closed -$5.2M
CSBR icon
362
Champions Oncology
CSBR
$72.1M
-99,763
Closed -$1.08M
CSTL icon
363
Castle Biosciences
CSTL
$979M
-26,357
Closed -$1.77M
DLB icon
364
Dolby
DLB
$5.79B
-20,933
Closed -$2.03M
DNLI icon
365
Denali Therapeutics
DNLI
$3.97B
-26,214
Closed -$2.2M
EDIT icon
366
Editas Medicine
EDIT
$442M
-30,895
Closed -$2.17M
ENTG icon
367
Entegris
ENTG
$23.2B
-14,348
Closed -$1.38M
EOSE icon
368
Eos Energy Enterprises
EOSE
$1.51B
-125,476
Closed -$3.72M
EVRI
369
DELISTED
Everi Holdings
EVRI
-130,934
Closed -$1.81M
AGNT
370
AGNT Inc
AGNT
$734M
-25,666
Closed -$810K
FATE icon
371
Fate Therapeutics
FATE
$326M
-23,209
Closed -$2.11M
FLUX icon
372
Flux Power
FLUX
$11.4M
-80,786
Closed -$1.39M
FLXS icon
373
Flexsteel Industries
FLXS
$311M
-40,524
Closed -$1.42M
FND icon
374
Floor & Decor
FND
$6.68B
-17,705
Closed -$1.64M
FOLD
375
DELISTED
Amicus Therapeutics
FOLD
-87,882
Closed -$2.03M

Similar funds

EAM Investors's Q1 2021 Portfolio in Review

As of Q1 2021, EAM Investors held 488 positions worth $664M, up 8.8% from $611M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.

EAM Investors withdrew a net $65.4M in Q1 2021, closing 166 positions and reducing 99 holdings. Its most notable exit was Artisan Partners, an estimated $7.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, EAM Investors opened a new position in Atkore worth $5.77M.

  • EAM Investors's largest Q1 2021 buy was Atkore: 80,194 shares worth $5.77M.
  • EAM Investors added most to The Shyft Group in Q1 2021, an estimated $2.05M increase.
  • EAM Investors's biggest Q1 2021 reduction was OptimizeRx, cutting an estimated $4.43M.
  • EAM Investors fully exited Artisan Partners in Q1 2021, selling an estimated $7.7M.
  • EAM Investors's ten largest holdings make up 8.6% of its $664M portfolio in Q1 2021.
  • EAM Investors opened 196 new positions and closed 166 in Q1 2021.
  • EAM Investors's portfolio value rose 8.8% quarter-over-quarter to $664M.

Based on EAM Investors's 13F filing for Q1 2021, filed 11 May 2021.